Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEPHD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $108,597
Award facts
- Contract value 100% obligated
- $108,597.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $108,597.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to streamline pharmaceutical supply chain operations across Department of Defense healthcare facilities worldwide. No set-aside designation was utilized for this award.
DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceutical products and medical consumables to federal agencies, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices. The company's established product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals supporting DoD military healthcare operations. As a prime vendor under the PPV-G GEN V contract structure, DMS Pharmaceutical Group has demonstrated consistent performance on multiple delivery orders issued by the DLA's Medical Supply Chain division, positioning the company as a critical supplier within the federal pharmaceutical supply chain with no identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DU26FEPHD?
SPE2DU26FEPHD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DU26FEPHD worth?
The government has obligated $108,597 on SPE2DU26FEPHD.
Is contract SPE2DU26FEPHD an order under another contract?
Yes. SPE2DU26FEPHD is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FEPHD competed?
The extent of competition for SPE2DU26FEPHD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award